USD 0.04
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -237.01 Thousand USD | 52.7% |
2022 | -501.12 Thousand USD | 33.34% |
2021 | -751.78 Thousand USD | 10.27% |
2020 | -837.85 Thousand USD | -58.64% |
2019 | -528.16 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -144.02 Thousand USD | -181.57% |
2024 Q1 | -51.15 Thousand USD | 69.3% |
2023 Q3 | 4431.00 USD | 110.85% |
2023 FY | -237.01 Thousand USD | 52.7% |
2023 Q4 | -166.58 Thousand USD | -3859.63% |
2023 Q1 | -34 Thousand USD | 68.97% |
2023 Q2 | -40.85 Thousand USD | -20.12% |
2022 Q2 | -106.29 Thousand USD | 41.19% |
2022 Q1 | -180.74 Thousand USD | 0.0% |
2022 FY | -501.12 Thousand USD | 33.34% |
2022 Q4 | -109.59 Thousand USD | -17.29% |
2022 Q3 | -93.43 Thousand USD | 12.09% |
2021 Q4 | - USD | 100.0% |
2021 FY | -751.78 Thousand USD | 10.27% |
2021 Q3 | -189.49 Thousand USD | -1.1% |
2021 Q2 | -187.43 Thousand USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 FY | -837.85 Thousand USD | -58.64% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 100.0% |
2020 Q2 | -208.32 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | -528.16 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BioQuest Corp. | - USD | Infinity% |
Clever Leaves Holdings Inc. | 6.55 Million USD | 103.615% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 100.107% |
Guardion Health Sciences, Inc. | 5.39 Million USD | 104.394% |
GSRX Industries Inc. | - USD | Infinity% |
High Sierra Technologies, Inc. | -56.39 Thousand USD | -320.293% |
Instadose Pharma Corp. | - USD | Infinity% |